Peritoneovenous shunt as a palliative option in generalized lymphatic anomaly.
Fuke N, Nishisho S, Tanaka A, Shimono R, Kusaka T.
Pediatr Int. 2021 Dec;63(12):1532-1534. doi: 10.1111/ped.14646. Epub 2021 Aug 18.
Peritoneovenous Shunt for Intractable Ascites in Children: A Series of 4 Cases.
Defert C, Marret JB, Lacaille F, Sissaoui S, Dupic L, Lardy H, Capito C, Chardot C.
J Pediatr Gastroenterol Nutr. 2021 Jul 1;73(1):e7-e10. doi: 10.1097/MPG.0000000000003131.
[Peritoneovenous shunt--indications, limits, results].
Schumpelick V, Riesener KP.
Chirurg. 1993 Jan;64(1):11-5.
Mitigation of Sarcopenia after Peritoneovenous Shunt Placement in Patients with Refractory Ascites.
Currie BM, Bakhtiar M, Nadolski GJ, Soulen MC.
J Vasc Interv Radiol. 2023 Apr;34(4):633-638. doi: 10.1016/j.jvir.2022.12.037. Epub 2022 Dec 20.
The peritoneovenous shunt: expectations and reality.
Moskovitz M.
Am J Gastroenterol. 1990 Aug;85(8):917-29.
The place of the peritoneovenous shunt in the treatment of ascites.
LeVeen EG, LeVeen HH.
ASAIO Trans. 1989 Apr-Jun;35(2):165-8. doi: 10.1097/00002480-198904000-00011.
Peritoneovenous shunt.
Sahi RP, Sinha KN, Mahendra NN.
Trop Gastroenterol. 1986 Jan-Mar;7(1):24-8.
Use of Peritoneovenous Shunt for the Management of Refractory Ascites.
Ayllón MD, Ciria R, Gómez-Luque I, Rodriguez-Perálvarez M, Padial A, Luque A, López-Cillero P, de la Mata M, Briceño J.
Transplant Proc. 2019 Jan-Feb;51(1):41-43. doi: 10.1016/j.transproceed.2018.04.089. Epub 2018 Jun 30.
Coagulopathy post peritoneovenous shunt.
LeVeen HH, Ip M, Ahmed N, Hutto RB, LeVeen EG.
Ann Surg. 1987 Mar;205(3):305-11. doi: 10.1097/00000658-198703000-00015.
Editorial Comment.
Cary C.
J Urol. 2020 Oct;204(4):823. doi: 10.1097/JU.0000000000001121.01. Epub 2020 Jul 22.
